Tessandra Stewart, Ph.D.
Affiliations: | 2011 | University of Washington, Seattle, Seattle, WA |
Area:
Neuroscience BiologyGoogle:
"Tessandra Stewart"Mean distance: 53433
Parents
Sign in to add mentor| Raimondo D'Ambrosio | grad student | 2011 | University of Washington | |
| (Cellular and In Vivo Characteristics of Electrophysical, Pharmacological and Morphological Properties of a Post-Traumatic Neocortical Epileptic Focus.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yu Z, Yang Y, Chan RB, et al. (2023) GV-971 attenuates α-Synuclein aggregation and related pathology. Cns Neuroscience & Therapeutics |
| Li N, Stewart T, Sheng L, et al. (2020) Immunoregulation of microglial polarization: an unrecognized physiological function of α-synuclein. Journal of Neuroinflammation. 17: 272 |
| Sheng L, Stewart T, Yang D, et al. (2020) Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson's disease pathogenesis. Acta Neuropathologica Communications. 8: 102 |
| Yu Z, Shi M, Stewart T, et al. (2020) Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction. Brain : a Journal of Neurology |
| Dong Y, Stewart T, Bai L, et al. (2020) Coniferaldehyde attenuates Alzheimer's pathology activation of Nrf2 and its targets. Theranostics. 10: 179-200 |
| Tian C, Liu G, Gao L, et al. (2019) Erythrocytic α-Synuclein as a potential biomarker for Parkinson's disease. Translational Neurodegeneration. 8: 15 |
| Stewart T, Shi M, Mehrotra A, et al. (2019) Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on Biomarkers. Journal of Alzheimer's Disease : Jad |
| Cilento EM, Jin L, Stewart T, et al. (2018) Mass Spectrometry: A Platform for Biomarker Discovery and Validation for Alzheimer's and Parkinson's Diseases. Journal of Neurochemistry |
| Dong Y, Stewart T, Zhang Y, et al. (2018) Anti-diabetic vanadyl complexes reduced Alzheimer's disease pathology independent of amyloid plaque deposition. Science China. Life Sciences |
| Wang H, Atik A, Stewart T, et al. (2018) Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study. Neurobiology of Disease |